Equities

Ladprao General Hospital PCL

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Ladprao General Hospital PCL

Actions
Health CareHealth Care Providers
  • Price (THB)3.66
  • Today's Change-0.02 / -0.54%
  • Shares traded127.10k
  • 1 Year change-10.73%
  • Beta0.1536
Data delayed at least 15 minutes, as of Feb 16 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Ladprao General Hospital Public Company Limited is principally engaged in the hospital business. The Company offers medical services and dermatology center, dental center, and ladprao reflective surgery center, and neurology center. It operates through two segments: Hospital, and Scientific Laboratory Testing & Research. The Hospital segment includes hospital services, healthcare centers, and service contracts with social security offices. The Scientific Laboratory Testing & Research segment offers scientific analytical and diagnostic services for food and agricultural, pharmaceutical, environmental covering product analysis, calibration of instruments and inspections. Its subsidiaries include Ladprao Health and Medical Product Co., Ltd., Asia Medical and Agricultural Laboratory and Research Center Public Company Limited, Asia Medical Laboratory and Research Center Co, Ltd., and others. Ladprao Health and Medical Product Co., Ltd. is engaged in selling health and medical products.

  • Revenue in THB (TTM)2.57bn
  • Net income in THB166.40m
  • Incorporated1990
  • Employees877.00
  • Location
    Ladprao General Hospital PCL2699 Ladprao Rd.Khlong Chaokhun Sing, Wang Thong LangBANGKOK 10310ThailandTHA
  • Phone+66 25302556
  • Fax+66 25398490
  • Websitehttp://www.ladpraohospital.com
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Aesthetic Connect PCL462.65m89.53m1.53bn86.0016.930.904614.373.300.25760.25761.334.820.266153.521,566.465,379,703.005.1517.565.3919.4750.2951.4919.3527.409.62860.460.0026---24.6118.74-27.6228.22----
Thonburi Medical Centre PCL1.11bn149.95m1.64bn311.0010.921.868.421.477.747.7457.3545.421.0993.0210.613,574,584.0014.699.5317.3411.5337.0033.6513.497.574.88--0.008128.59-13.441.5433.2041.490.088--
Safe Fertility Group Pcl699.20m124.63m1.95bn194.0015.611.1511.322.780.410.412.305.560.35957.5041.573,604,122.006.268.546.689.1655.4752.9617.4118.5314.06--0.0366---2.18-2.60-17.21-7.61-18.39--
Aikchol Hospital PCL1.75bn139.91m1.98bn1.34k14.140.92728.661.130.93330.933311.7014.240.706231.149.101,313,675.005.638.106.319.2819.1820.637.9810.566.021,458.180.005150.55-1.871.07-32.72-0.93978.13-0.9051
Nakornthon Hospital PCL1.98bn203.48m2.18bn958.001.571.106.431.102.602.604.883.720.92446.0915.262,069,653.009.48--12.12--28.80--10.26--1.7133.730.0406---0.8836---17.21------
Ladprao General Hospital PCL2.57bn166.40m2.65bn877.0015.921.346.011.030.23110.23113.582.740.848831.367.892,935,026.007.038.138.6710.1426.5726.568.289.571.5010.880.162469.187.438.6923.01-6.68-2.177.57
Ratchaphruek Hospital PCL1.14bn173.40m2.72bn783.0015.401.5810.802.390.32340.32342.123.160.597930.8911.131,454,308.009.1011.649.9013.2533.5037.4515.2319.583.03402.980.002155.53-3.056.62-6.4612.34-26.9515.68
Master Style PCL2.05bn371.17m3.14bn819.008.450.92156.001.531.231.236.7911.290.49418.28159.522,503,143.008.9519.049.8122.6657.4557.4718.1122.500.4225--0.1577--11.3938.8325.5053.5372.52--
Mahachai Hospital PCL6.44bn132.68m3.54bn4.54k26.651.574.270.5490.82930.829340.2514.100.554732.106.431,418,665.001.021.361.542.0318.3221.561.852.910.3861.480.674435.07-0.002321.46-75.13-9.04-33.31-3.58
Nonthavej Hospital PCL2.37bn280.50m3.78bn1.40k13.461.377.961.591.751.7514.8317.180.768333.269.821,696,156.009.0810.5510.0011.6827.1528.7611.8213.244.74--0.0060.360.51741.94-6.96-3.0217.24-2.81
Rajthanee Hospital PCL2.64bn252.58m3.87bn1.33k15.021.829.081.460.85910.85918.987.100.615431.965.321,982,343.005.5220.887.6229.5222.1538.118.9725.040.59465.230.380972.0316.649.1117.484.4922.86-8.64
Patrangsit Healthcare Group PCL2.44bn304.05m3.93bn1.55k12.931.839.661.611.011.018.137.160.995427.497.561,578,876.0012.4114.2914.2817.8124.6426.6612.4612.324.62743.660.0034--6.329.54-2.7933.20-17.14--
Data as of Feb 16 2026. Currency figures normalised to Ladprao General Hospital PCL's reporting currency: Thai Baht THB

Institutional shareholders

0.01%Per cent of shares held by top holders
HolderShares% Held
FIL Investments Internationalas of 30 Jun 202523.90k0.00%
Lazard Asset Management LLCas of 31 Jan 202616.00k0.00%
Dimensional Fund Advisors LPas of 30 Nov 20250.000.00%
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.